Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 144

    1.

    Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.

    Conway K, Parrish E, Edmiston SN, Tolbert D, Tse CK, Moorman P, Newman B, Millikan RC.

    Breast Cancer Res. 2007;9(3):R36.

    PMID:
    17553133
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.

    Conway K, Parrish E, Edmiston SN, Tolbert D, Tse CK, Geradts J, Livasy CA, Singh H, Newman B, Millikan RC.

    Breast Cancer Res. 2005;7(6):R871-80. Epub 2005 Sep 6.

    PMID:
    16280033
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    4.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    5.

    Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.

    Brinton LA, Gammon MD, Malone KE, Schoenberg JB, Daling JR, Coates RJ.

    Contraception. 1997 Apr;55(4):197-203.

    PMID:
    9179450
    [PubMed - indexed for MEDLINE]
    6.

    Breast cancer among young U.S. women in relation to oral contraceptive use.

    White E, Malone KE, Weiss NS, Daling JR.

    J Natl Cancer Inst. 1994 Apr 6;86(7):505-14.

    PMID:
    8133534
    [PubMed - indexed for MEDLINE]
    7.

    Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.

    Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.

    Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):413-9.

    PMID:
    10350436
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Use of oral contraceptives and risk of breast cancer in young women.

    Ursin G, Ross RK, Sullivan-Halley J, Hanisch R, Henderson B, Bernstein L.

    Breast Cancer Res Treat. 1998 Jul;50(2):175-84.

    PMID:
    9822222
    [PubMed - indexed for MEDLINE]
    9.

    Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54.

    Mayberry RM.

    Ann Epidemiol. 1994 May;4(3):205-13.

    PMID:
    8055121
    [PubMed - indexed for MEDLINE]
    10.

    Oral contraceptive agents and breast cancer: a population-based case-control study.

    Rohan TE, McMichael AJ.

    Med J Aust. 1988 Nov 21;149(10):520-6.

    PMID:
    3185321
    [PubMed - indexed for MEDLINE]
    11.

    Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women.

    Sweeney C, Giuliano AR, Baumgartner KB, Byers T, Herrick JS, Edwards SL, Slattery ML.

    Int J Cancer. 2007 Dec 1;121(11):2517-23.

    PMID:
    17657739
    [PubMed - indexed for MEDLINE]
    12.

    Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.

    Milne RL, Benítez J, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Arias JI, Zamora MP, Burwinkel B, Bartram CR, Meindl A, Schmutzler RK, Cox A, Brock I, Elliott G, Reed MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Schürmann P, Bremer M, Hillemanns P, Dörk T, Devilee P, van Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Liu J, Li Y, Ahmed S, Dunning AM, Maranian M, Pharoah PD, Chenevix-Trench G, Beesley J; kConFab Investigators; AOCS Group, Bogdanova NV, Antonenkova NN, Zalutsky IV, Anton-Culver H, Ziogas A, Brauch H, Justenhoven C, Ko YD, Haas S, Fasching PA, Strick R, Ekici AB, Beckmann MW, Giles GG, Severi G, Baglietto L, English DR, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Turnbull C, Hines S, Renwick A, Rahman N, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo KY, Noh DY, Mannermaa A, Kataja V, Kosma VM, García-Closas M, Chanock S, Lissowska J, Brinton LA, Chang-Claude J, Wang-Gohrke S, Shen CY, Wang HC, Yu JC, Chen ST, Bermisheva M, Nikolaeva T, Khusnutdinova E, Humphreys MK, Morrison J, Platte R, Easton DF; Breast Cancer Association Consortium.

    J Natl Cancer Inst. 2009 Jul 15;101(14):1012-8. Epub 2009 Jun 30.

    PMID:
    19567422
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Birthweight, parental age, birth order and breast cancer risk in African-American and white women: a population-based case-control study.

    Hodgson ME, Newman B, Millikan RC.

    Breast Cancer Res. 2004;6(6):R656-67. Epub 2004 Sep 22.

    PMID:
    15535848
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.

    Herynk MH, Parra I, Cui Y, Beyer A, Wu MF, Hilsenbeck SG, Fuqua SA.

    Clin Cancer Res. 2007 Jun 1;13(11):3235-43.

    PMID:
    17545528
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan.

    Huang CS, Shen CY, Chang KJ, Hsu SM, Chern HD.

    Br J Cancer. 1999 Aug;80(11):1838-43.

    PMID:
    10468307
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Estrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast.

    Tebbit CL, Bentley RC, Olson JA Jr, Marks JR.

    Genes Chromosomes Cancer. 2004 May;40(1):51-4.

    PMID:
    15034868
    [PubMed - indexed for MEDLINE]
    17.

    Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

    Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC.

    JAMA. 1998 Mar 25;279(12):915-21.

    PMID:
    9544765
    [PubMed - indexed for MEDLINE]
    Free Article
    18.
    19.

    A case-control study of oral contraceptive use and incident breast cancer.

    Rosenberg L, Zhang Y, Coogan PF, Strom BL, Palmer JR.

    Am J Epidemiol. 2009 Feb 15;169(4):473-9. Epub 2008 Dec 13.

    PMID:
    19074777
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?

    Khoo SK, Chick P.

    Med J Aust. 1992 Jan 20;156(2):124-32. Review.

    PMID:
    1736053
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk